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High prevalence of altered cardiac repolarization
in patients with COPD
Noriane A Sievi1,2, Christian F Clarenbach1, Giovanni Camen1, Valentina A Rossi1, Arnoldus JR van Gestel1
and Malcolm Kohler1,3,4*
Abstract
Background: Altered cardiac repolarization and increased dispersion of repolarization have been identified as risk
factors for sudden cardiac death (SCD). The prevalence of and the mechanisms contributing to altered cardiac
repolarization are currently unknown in COPD.
Methods: In 91 COPD patients, 32 controls matched for age, cardiovascular risk and medication, and 41 healthy
subjects, measures of cardiac repolarization and dispersion of repolarization (QTc interval, QT dispersion) were
derived from 12-lead electrocardiography (ECG). Prevalence rates of heart rate corrected QT (QTc) >450ms and QT
dispersion >60ms were determined to assess the number of subjects at risk for SCD. Univariate and multivariate
analyses were used to identify possible factors contributing to altered cardiac repolarization.
Results: QTc was found to be prolonged in 31.9% and QT dispersion in 24.2% of the COPD patients compared to
12.5% in matched controls and 0% in healthy subjects. The QTc interval was longer in COPD patients compared to
matched and healthy controls respectively (437.9 ± 29.5 vs. 420.1 ± 25.3 ms, p = 0.001 and vs. 413.4 ± 18.2 ms, p < 0.001).
QT dispersion was significantly increased in COPD patients compared to healthy subjects (45.4 (34.8 , 59.5) vs. 39.7
(29.3 , 54.8) ms, p = 0.049). Only oxygen saturation was independently associated with QTc duration in multivariate
analysis (β = -0.29, p = 0.015).
Conclusion: One third of a typical COPD population has altered cardiac repolarization and increased dispersion of
repolarization, which may be related to hypoxia. Altered cardiac repolarization may expose these patients to an
increased risk for malignant ventricular arrhythmias and SCD.
Background
Chronic obstructive pulmonary disease (COPD) is associ-
ated with an increased risk of cardiovascular morbidity
and mortality [1-3]. Previous population-based studies
suggested that patients with COPD have a two to three
fold increased risk of sudden cardiac death (SCD) [4].
However, the mechanisms underlying the association
between COPD and SCD are currently unclear and
predictors of malignant cardiac arrhythmias and SCD
in COPD have not been defined.
Alteration of cardiac repolarization is an important
mechanism for the development of malignant arrhythmias
and the occurrence of SCD [5-7]. Measures derived from
the surface electrocardiography (ECG) represent the disper-
sion of repolarization and the electrical inhomogeneity
of the ventricles during repolarization [7,8]. The findings of
previous studies in patients with heart failure [9], patients
with long QT syndrome [10] and elderly persons [11] indi-
cated an association between alteration of measures of car-
diac repolarization, such as QT interval and QT dispersion
with the development of malignant arrhythmia and SCD.
Evidence from longitudinal studies suggests that a low
forced expiratory volume in 1 s (FEV1) is associated with an
increased risk for ischemic heart and cerebral disease and
SCD, even after correcting for conventional cardiovascular
risk factors [12,13]. It has also been suggested that COPD
patients may have a higher frequency of cardiac arrhyth-
mias and the severity of airflow obstruction seems to be as-
sociated with the occurrence of arrhythmia [14,15].
Preliminary evidence from a small case-control study
suggests that increased maximal QT interval is associated
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with the development of ventricular arrhythmia in pa-
tients with COPD [16]. However, the prevalence of and
the mechanisms contributing to altered cardiac repolariza-
tion in patients with COPD are currently unknown.
Therefore, the aim of this study was to evaluate the
prevalence of and possible factors contributing to altered
cardiac repolarization in a group of COPD patients.
Methods
Subjects
COPD patients
157 patients aged between 40 and 75 years with objectively
confirmed COPD according to GOLD-guidelines [17] were
assessed for eligibility in the pulmonary outpatient clinic
at the University Hospital of Zurich, Switzerland between
October 2009 and January 2013. Patients were excluded if
they had suffered from a COPD exacerbation within the
last 6 weeks or if they suffered from mental or physical
disability precluding informed consent or compliance with
the protocol.
Matched control subjects
The patient database of the Pulmonary Division of the
University Hospital Zurich, Switzerland was screened for
control subjects with normal lung function and matched
for age, Pocock risk score use of beta blockers and medi-
cation affecting QT duration.
Healthy control subjects
Subjects were eligible for the study if they were between
18 and 75 years old and healthy. Exclusion criteria were a
previous diagnosis of any lung disease, arterial hyperten-
sion, any aortic or cardiac disease.
The study was conducted in accordance with the dec-
laration of Helsinki of the World Medical Association.
The Ethics Committee of the Canton of Zurich approved
the study (EK-ZH-NR: 1734) and all subjects gave written
informed consent to participate when data were obtained
for research purposes.
Measurements
Cardiovascular risk and medication
The Pocock risk score was used to predict the individuals’
5-year risk of death due to a cardiovascular cause [18].
The Pocock risk score is calculated from 11 known
cardiovascular risk factors, including sex, age, smoking
status, systolic blood pressure, cholesterol, creatinine,
height, diabetes, previous myocardial infarction, stroke
and left ventricular hypertrophy.
Patients and control subjects who were included in the
study were asked if they used medications affecting the
QT interval according to the International Registry of
Drug-induced Arrhythmias maintained by the Georgetown
University [19].
Respiratory variables
All participants underwent standard pulmonary functional
testing according to American Thoracic Society guidelines
[20] to measure forced expiratory volume in one second
(FEV1) and forced vital capacity (FVC).
Oxygen saturation (SaO2) was measured with a fingertip
oximeter PC-60C after the participants rested 5min in
supine position.
Electrocardiography
Patients and control subjects were asked to abstain from
alcohol, tobacco, or caffeine on the day the measure-
ments were performed. Room temperature and lighting
were set at the same level for all measurements. The pa-
tients rested for five minutes in supine position before
measurements were performed. For all electrocardio-
graphic recordings a commercially available 12-lead ECG
(AT 104 PC, Schiller-Reomed AG, Switzerland) was used
and set at 25-mm/s paper speed and 10-mm/mV ampli-
tude. Measurements of the ECG intervals were performed
in duplicate with dedicated ECG analysis software (DatInf®
Measure 2.1d, DatInf GmbH, Tübingen, Germany) by two
investigators who were blinded to the patient’s data as pre-
viously described [21]. The mean of the ECG interval
measurements by the two investigators was calculated and
used for statistical analysis. Four consecutive heart cycles
were analysed for each lead. The mean value for each lead
of the twelve leads was calculated. Measures of cardiac
repolarization were determined as indicated in Figure 1.
The QT interval was defined as the time from the earliest
onset of the QRS complex to the end of the T wave [22].
The end of the T wave was defined as the cutting point of
the tangent to the downward slope of the T-wave and the
isoelectric line [23]. As a measurement of dispersion of re-
polarization, QT dispersion was defined as the difference
between the lead with the maximal and the lead with the
minimal QT interval duration [24].
QTc (QT interval corrected for heart rate) was corrected
for heart rate by using the Bazett formula [25].
Data analysis and statistics
All results are shown as mean values and standard deviation
(SD) unless otherwise stated. Statistical analysis was
performed with Statistica V6.0 (StatSoft, Tulsa, OK, USA)
and STATA 12 (StataCorp, Texas, USA). Differences in QTc
interval duration, cardiovascular risk factors, respiratory var-
iables and use of medications between COPD patients,
matched controls and healthy control subjects respectively
were assessed by one-way ANOVA and χ2 tests. Kruskal
Wallis test was used to compare QT dispersion between
groups. Post hoc analysis was assessed for variables that
showed a p-value of <0.1 across the three groups. For
QTc, altered cardiac repolarization was defined as a value
of >450ms and for QT dispersion of >60ms [16,26].
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Univariate regression analysis was used to investigate
associations between repolarization duration (dependent
variable) and cardiovascular risk factors as well as re-
spiratory variables and medications. Multivariate ana-
lysis involved regression of variables that showed a
univariate regression p-value of <0.1 with adjustment for
potential confounders (age). Residual analysis of the model
was performed to check the regression assumptions. A
two-sided p-value of <0.05 was considered to be statis-
tically significant.
Results
Study participants
157 COPD patients were screened for eligibility for this
study. 91 COPD patients (34% GOLD stage I/II, 27% III,
39% IV), 32 control subjects matched for age, cardiovas-
cular risk and medication and 41 healthy subjects en-
tered the final analysis (Figure 2). Patient characteristics
are shown in Table 1.
Prevalence of altered repolarization measures
The QTc interval was significantly longer in COPD
patients compared to matched controls (437.9 ± 29.5 vs.
420.1 ± 25.3 ms, p = 0.001) and compared to healthy
subjects (437.9 ± 29.5 vs. 413.4 ± 18.2 ms, p < 0.001). QT
dispersion showed a non-significant trend to be increased
in COPD patients compared to matched controls (45.4
(34.8, 59.5) vs. 39.7 (29.3, 54.8) ms, p = 0.102). COPD
patients showed a significantly increased QT dispersion
compared to healthy subjects (45.4 (34.8, 59.5) vs. 40.8
(33.0, 48.8) ms, p = 0.049).
Of 91 COPD patients, 31.9% showed a prolonged QTc
interval >450ms compared to 12.5% in matched controls
(p = 0.033) and 0% in healthy subjects (p < 0.001). 24.2% of
the COPD patients had an increased QT dispersion >60 ms
compared to 12.5% in matched controls (p = 0.164) and 0%
in healthy subjects (p < 0.001) (Figure 3).
Determinants of altered cardiac repolarization
Univariate regression analysis
QTc was associated with age, pack years of smoking, coron-
ary artery disease (CAD), FEV1% pred., FVC% pred., SaO2,
the use of combined inhaled long-acting β-adrenergic and
steroid, anticholinergic medication and statins (Table 2).
QT dispersion showed a significant association with pack
years of smoking (β = 0.17, p = 0.033) and the use of statins
(β = 0.16, p = 0.041).
Multivariate analysis
Table 3 shows a multiple regression model with QTc as
dependent and age, gender, pack years of smoking, Pocock
risk score, CAD, FEV1% pred., SaO2, use of combined
inhaled long-acting β-adrenergic and steroid, use of
anticholinergic medication and consumption of statins
as independent variables. SaO2 was the only independently
associated variable. In Multivariate analysis performed
for QT dispersion as dependent and age, gender, BMI,
pack years of smoking, SaO2, use of beta blocker, combined
inhaled long-acting β-adrenergic and steroid and con-
sumption of statins as independent variables, none of
the variables showed an independent association.
Discussion
This study investigated the prevalence of altered cardiac
repolarization in a heterogeneous group of COPD patients
and evaluated possible underlying risk factors. The main
findings of this study are that approximately one third of a
typical COPD population has altered cardiac repolariza-
tion and increased dispersion of repolarization, which may
be related to hypoxia. Altered cardiac repolarization may
expose these patients to an increased risk for malignant
ventricular arrhythmias and SCD.
Several pathologies have been reported to increase the
risk of SCD including CAD, cardiomyopathies, congeni-
tal heart disease and electrophysiological abnormalities
including long QT syndrome [27].
A prolonged QT interval and increased QT dispersion
are markers of an increased risk for malignant cardiac
arrhythmia and SCD [9,26]. The QT interval represents
the electrocardiographic correlate of ventricular de- and
repolarization including the vulnerable period for reentry
tachycardia. As such, QTc prolongation to >450 ms has
been identified as a risk factor for malignant ventricular
Figure 1 The length of the QT interval was obtained by identifying
the QRS onset and the point at which the downward slope of the
T wave returns to baseline.
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arrhythmias and SCD [26,28]. QT dispersion reflects spatial
differences in myocardial recovery time. Previous studies
have shown that an increase in QT dispersion >60ms is
associated with the development of malignant ventricular
arrhythmias [16] and SCD [9].
In large population-based studies including elderly sub-
jects, the prevalence of an altered QTc interval has been
estimated to be approximately 8% [11]. In contrast, the
COPD patients in the current study showed a fourfold
higher prevalence of an altered QTc interval compared to
the general population. In a case-control study, investigat-
ing the risk of SCD in patients with coronary heart disease
with and without prolonged QTc interval, the prevalence
of prolonged QTc interval was 39% in the group with
subsequent SCD [29]. This prevalence of altered QTc
in SCD patients is comparable with the findings of the
current study in COPD patients.
In a retrospective study including 162 chronic heart
disease patients, the prevalence of increased QT dis-
persion >60 ms was 24% [30], which is similar to our ob-
servations in COPD patients (24%). These findings suggest
a comparable prevalence of increased QT dispersion in
patients with chronic heart disease and COPD patients.
There are some previous studies examining possible
factors leading to an alteration in cardiac repolarization
in COPD patients, however, the COPD patients in these
studies [16,31-33] were free from comorbidities. Zulli et al.
[31] found a significant univariate association between QT
Figure 2 Study flow.
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dispersion with FEV1% pred. and FVC% pred. respectively
in COPD patients. However, in the multivariate analysis
correcting for covariates, this association did not remain
statistically significant. Yildiz et al. [16] compared 30 COPD
patients with and without increased QT dispersion re-
garding possible factors influencing QT dispersion and
found no independently associated factors. Similarly,
in our study, only pack years of smoking and use of statins
was statistically significantly associated with QT dispersion
in the univariate analysis. However, after correcting for
age, BMI, SaO2 and use of medication, none of the pos-
sible influencing risk factors were independently asso-
ciated with QT dispersion.
None of the previously described studies [16,31] exam-
ined possible factors leading to an altered QTc interval
in COPD patients. In the current study, age, pack years
of smoking, Pocock risk score, respiratory variables,
use of combined inhaled long-acting β-adrenergic and
steroid and consumption of statins were significantly
associated with a QTc >450ms in univariate analysis. Only
SaO2 remained statistically significantly associated with
QTc >450 ms after correction for covariates in the multi-
variate analysis. Thus, hypoxia may be a risk factor for a
prolonged QTc interval. There is some evidence that
hypoxia may prolong repolarization duration. In a study by
Roche et al. [34], healthy subjects were exposed to nor-
mobaric hypoxic conditions and it was found that hypoxia
significantly prolonged the QTc interval. In 12 COPD
patients, Tirlapur et al. [35] observed that patients who
had a low mean basal SaO2 (<80%) showed electrocar-
diographic changes such as a prolonged QTc interval.
These findings are somewhat in contrast to the study
by Sarubbi et al. [33], where QTc was measured in 15
hypoxemic/hypercapnic COPD patients before and
after oxygen therapy and was not significantly reduced
after 24 h of oxygen therapy. Thus it is still a matter of
debate whether hypoxia affects cardiac repolarization
and the underlying mechanism through which hypoxia
may possibly influence cardiac repolarization remains
currently unknown.
There is some evidence that autonomic neuropathy
may results in prolonged cardiac repolarization in COPD
Table 1 Participant characteristics
COPD N = 91 Matched controls N = 32 Healthy controls N = 41
Demographics and cardiovascular risk
Age, y 62 (7.1)† 62 (5.9)¶ 30 (8.7)
Male/Female 61/30 24/8 24/17
BMI, kg/m2 27.9 (6.0)† 29.2 (4.4)¶ 22.8 (3.1)
Current smokers, N (%) 19 (21) 7 (22) 5 (13)
Pack years of smoking, N 43 (23.7)*† 9 (18.2) 1 (5.1)
Arterial hypertension, N (%) 49 (54)† 23 (72)¶ 0 (0)
CAD, N (%) 18 (20)† 3 (9)¶ 0 (0)
Arrhythmia, N (%) 19 (21) 8 (25) 4 (10)
Diabetes, N (%) 13 (14)† 3 (9)¶ 0 (0)
Cholesterol, mmol/l 5.2 (1.1) 4.9 (1.0) 5.1 (1.1)
Pocock risk score, % 2.2 (2.1)† 2.1 (0.9)¶ 0.3 (0.3)
Respiratory variables
FEV1% pred. 45 (22.4)*
† 104 (16.0) 100 (11.1)
FVC% pred. 77 (18.3)*† 108 (14.0) 104 (8.2)
FEV1/FVC,% 45 (15.2)*
† 78 (5.5) 80 (5.9)
SaO2, kPa 93.8 (3.4)
† 95.1 (1.3)¶ 98.0 (1.4)
Medication
Medication affecting QT, N (%) 12 (13)† 4 (13)¶ 0 (0)
Beta blockers, N (%) 18 (20)† 10 (31)¶ 0 (0)
Antihypertensive medication, N (%) 47 (52)† 19 (59)¶ 0 (0)
Anticholinergic medication, N (%) 62 (68)*† 0 (0) 0 (0)
Combined inhaled long-acting β-adrenergic and steroid, N (%) 53 (58)*† 0 (0) 0 (0)
Statins, N (%) 30 (33)† 11 (34)¶ 0 (0)
Values are mean (SD). *p < 0.05 COPD vs. matched controls. †p < 0.05 COPD vs. healthy controls. ¶p < 0.05 matched controls vs. healthy controls. BMI: body mass
index; CAD: coronary artery disease; FEV1: forced expiration in one second; FVC: forced volume capacity; SaO2: oxygen saturation.
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patients. In a case-control study by Stewart et al. [32], 17
COPD patients with autonomic neuropathy were compared
to 17 COPD patients without autonomic neuropathy. QTc
was significantly longer in COPD patients with autonomic
neuropathy. However, autonomic neuropathy was not mea-
sured in our study and thus we cannot directly compare
the results of the study by Stewart et al. with our findings.
The current study has some limitations. We performed
standard resting 12-lead ECG and not continuous 24-h
ECG. Therefore it is not possible to evaluate the prevalence
of alteration in cardiac repolarization both during a longer
daytime period and during sleep. Furthermore, the
cross-sectional study design does not allow to establish a
causal relationship between altered cardiac repolarization
in COPD patients and malignant ventricular arrhythmias
and SCD, respectively. If prolonged cardiac repolarization
Figure 3 The distribution of repolarization duration of QTc is illustrated. Each point represents the repolarization duration of an individual
subject. The dotted line marks the threshold indicating altered cardiac repolarization and thus risk for SCD.
Table 2 Univariate regression analysis of predictors for
QTc in all participants
β 95% confidence
interval
p-value
Cardiovascular risk
Age, y 0.30 0.15/0.45 <0.001*
Male/Female −0.08 −0.23/0.08 0.317
BMI, kg/m2 0.13 −0.02/0.28 0.104
Current smoker, N (%) −0.01 −0.16/0.15 0.934
Pack years of smoking, N 0.28 0.13/0.44 <0.001*
Pocock risk score, % 0.17 −0.00/0.35 0.054
Respiratory variables
FEV1% pred. −0.30 −0.48/-0.12 0.001*
FVC% pred. −0.32 −0.50/-0.15 <0.001*
SaO2, % −0.34 −0.51/-0.17 <0.001*
Medication
Medication affecting QT, N (%) 0.13 −0.03/0.28 0.108
Beta blocker, N (%) 0.05 −0.11/0.20 0.558
Combined inhaled long-acting
β-adrenergic and steroid, N (%)
0.28 0.13/0.43 <0.001*
Statins, N (%) 0.23 0.07/0.38 0.004*
*p < 0.05; QTc: QT interval corrected for heart rate; BMI: body mass index;
FEV1: forced expiration in one second; FVC: forced vital capacity; SaO2: arterial
oxygen saturation.
Table 3 Multiple regression analysis of predictors for QTc
in all participants
β 95% confidence
interval
p-value
Age, y −0.04 −0.28/0.19 0.713
Pack years of smoking, N −0.11 −0.33/0.12 0.349
Pocock risk score, % 0.07 −0.17/0.30 0.587
FEV1% pred. −0.16 −0.42/0.11 0.244
SaO2,% −0.29 −0.51/-0.07 0.011*
Combined inhaled long-acting
β- adrenergic and steroid, N (%)
0.11 −0.13/0.35 0.375
Statins, N (%) 0.08 −0.12/0.29 0.426
*p < 0.05; QTc: QT interval corrected for heart rate; FEV1: forced expiration in
one second; SaO2: arterial oxygen saturation.
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promotes sudden cardiac death in COPD patients is
currently unknown. Further controlled and longitudinal
studies are needed to evaluate if prolonged cardiac re-
polarization promotes malignant ventricular arrhythmia
and SCD in COPD patients.
Conclusion
In conclusion, our findings suggest that one third of a
typical COPD population has altered cardiac repolarization
and increased dispersion of repolarization, which may
be related to hypoxia. Altered cardiac repolarization may
expose these patients to an increased risk for malignant
ventricular arrhythmias and SCD.
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